GeneDx Holdings (WGS) Current Assets (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Current Assets data on file, last reported at $270.6 million in Q1 2026.

• Current Assets for Q1 2026 came in at $270.6 million, up 19.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $270.6 million (up 19.84% YoY), and the FY2025 annual result was $268.3 million, up 35.52% from the prior year.
• Current Assets climbed to $270.6 million in Q1 2026 per WGS's latest filing, from $268.3 million in the prior quarter.
• Over five years, Current Assets peaked at $410.4 million in Q1 2022 and troughed at $162.2 million in Q2 2024.
• A 5-year average of $240.5 million and a median of $213.3 million in 2023 frame the typical range for Current Assets.
• On a YoY basis, Current Assets climbed as much as 306.72% in 2022 and fell as far as 56.03% in 2022.
• A 5-year view of Current Assets shows it stood at $212.6 million in 2022, then decreased by 14.24% to $182.3 million in 2023, then advanced by 8.57% to $198.0 million in 2024, then soared by 35.52% to $268.3 million in 2025, then grew by 0.87% to $270.6 million in 2026.
• Business Quant data shows WGS's Current Assets at $270.6 million in Q1 2026, $268.3 million in Q4 2025, and $237.6 million in Q3 2025.